Rizk, M. M., Stanley, B., Choo, T., Pavlicova, M., Scodes, J. M., Rotrosen, J., & Nunes, E. V. (2025). Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexone. American Journal of Drug & Alcohol Abuse, 51(5), 658. https://doi.org/10.1080/00952990.2025.2524110
Chicago Style (17th ed.) CitationRizk, Mina M., Barbara Stanley, Tse-Hwei Choo, Martina Pavlicova, Jennifer M. Scodes, John Rotrosen, and Edward V. Nunes. "Suicidal Ideation in Adults with Opioid Use Disorder Treated with Buprenorphine-naloxone Versus Extended-release Naltrexone." American Journal of Drug & Alcohol Abuse 51, no. 5 (2025): 658. https://doi.org/10.1080/00952990.2025.2524110.
MLA (9th ed.) CitationRizk, Mina M., et al. "Suicidal Ideation in Adults with Opioid Use Disorder Treated with Buprenorphine-naloxone Versus Extended-release Naltrexone." American Journal of Drug & Alcohol Abuse, vol. 51, no. 5, 2025, p. 658, https://doi.org/10.1080/00952990.2025.2524110.